RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Multiple Sclerosis - Medicare Access (Medicare patients only)
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Acetylcarnitine
- Amantadine
- Ampyra
- Armodafinil
- Aubagio
- Avonex
- Azathioprine
- Baccilus Of Calmette And Guerin
- Baclofen
- Bafiertam
- Betaseron
- Botox
- Botulinum Toxin Injection
- Briumvi
- Carbamazepine
- Carimune
- Cladribine
- Copaxone
- Cosyntropin
- Cyclophosphamide
- Daclizumab Soln
- Depo Medrol
- Diroximel Fumarate
- Dronabinol
- Extavia
- Fleqsuvy
- Gabitril
- Gammagard
- Gammaplex
- Gamunex-c
- Gilenya
- Glatiramer Acetate Injection
- Glatopa
- H.p. Acthar Gel
- Inosine Pranobex
- Interferon Alfa-2b
- Interferon Beta
- Isoniazid
- Kesimpta
- Lemtrada
- Leustatin
- Lofepramine
- Maprotiline
- Mavenclad
- Mayzent
- Methotrexate
- Mitoxantrone Hydrochloride
- Modafinil
- Muromonab-cd3
- Natalizumab
- Nuedexta
- Nuvigil
- Ocrevus
- Ocrevus Zunovo
- Ondansetron
- Pediaderm Ta
- Penicillamine
- Pentoxifylline
- Pirfenidone
- Plegridy
- Ponvory
- Prednisolone
- Progabide
- Provigil
- Rebif
- Rebif Rebidose
- Rituxan
- Rituxan Hycela
- Rituximab
- Rituximab-pvvr
- Ruxience
- Siponimod
- Solu Medrol
- Sulfasalazine
- Symmetrel
- Tascenso
- Tecfidera
- Tetrazepam
- Tiagabine Hydrochloride
- Triamcinolone
- Truxima
- Tyruko
- Tysabri
- Verapamil Hydrochloride
- Vumerity
- Zeposia
- Zinbryta
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of multiple sclerosis.
Grant Utilization
HealthWell estimates that patients use an average of $5,150 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Multiple Sclerosis
Multiple sclerosis is a disease in which the immune system attacks the central nervous system (brain, spinal cord, and optic nerves) and is thought to be triggered, in genetically susceptible individuals, by a combination of one or more environmental factors. People living with MS may experience a range of symptoms such as numbness in the limbs, paralysis, or loss of vision. Symptoms of the disease can also go undetected, making it difficult to diagnose. Source: National Multiple Sclerosis Society
Additional Educational Resources
- National Multiple Sclerosis Society (Educational Resource Only)
- Can Do Multiple Sclerosis (Educational Resource Only)
- The Consortium of Multiple Sclerosis Centers
- Multiple Sclerosis Association of America
You may also visit our Resource List to view other copayment organizations that may provide assistance.
